Dana is a Precision Medicine leader with over 15 years of experience across diagnostics, pharma, and biotech. As Principal at Diaceutics, she partners with clients to shape and execute diagnostic commercialization strategies—supporting CDx development and partnerships, patient identification, customer engagement strategies, launch planning, and life cycle management initiatives. Dana brings deep insight into evolving marketing landscapes, helping pharma and biotech teams align diagnostics with strategic goals and deliver value across oncology and rare disease.